Ironwood Pharmaceuticals | IRWD - PE Price to Earnings


Ironwood Pharmaceuticals reported 204.24 in PE Price to Earnings for its fiscal quarter ending in December of 2024.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Almirall 79.43 0.3 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amarin 91.05 88.3 Jun/2023
Astellas Pharma 7.31 2.04 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Charles River Laboratories 43.58 0.86 Dec/2025
Emergent BioSolutions 14.4 2.25 Sep/2022
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 23.16 7.7 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pacira 52.68 23.44 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 27.27 0 Sep/2025
Takeda 235.05 184.95 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023